hmr 1766 has been researched along with Chronic Kidney Failure in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amann, K; Benz, K; Linz, W; Orth, SR; Rütten, H; Schindler, U; Simonaviciene, A | 1 |
1 other study(ies) available for hmr 1766 and Chronic Kidney Failure
Article | Year |
---|---|
Blood pressure-independent effect of long-term treatment with the soluble heme-independent guanylyl cyclase activator HMR1766 on progression in a model of noninflammatory chronic renal damage.
Topics: Animals; Blood Pressure; Disease Models, Animal; Disease Progression; Guanylate Cyclase; Heme; Kidney Failure, Chronic; Male; ortho-Aminobenzoates; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Soluble Guanylyl Cyclase; Sulfonamides; Time | 2007 |